Hong Seongwook, Kim Hyunjeong, Park Junmo
Department of Anesthesiology and Pain Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, South Korea.
Medicine (Baltimore). 2019 Apr;98(15):e15159. doi: 10.1097/MD.0000000000015159.
Despite recent advances in gastric cancer surgery, open gastrectomy is often needed to treat gastric cancer. Due to the large incision in the abdomen, the amount of opioid required during surgery increases and postoperative pain becomes worse. It is well known that postoperative pain has a negative impact on the patient's immune system. Herein, we performed an ultrasound-guided bilateral rectus sheath block (RSB) in patients undergoing open gastrectomy under general anesthesia and analyzed the analgesic effectiveness of RSB in open gastrectomy.
A total of 46 patients scheduled for open gastrectomy were randomly divided into 2 groups: Group A (n = 21) consisted of patients who received an RSB using 40 mL of 0.375% ropivacaine under ultrasound guidance and Group B (n = 20) consisted of patients who received an RSB using 40 mL of normal saline. An electronic injection pump was connected to each patient for patient-controlled analgesia (PCA) immediately after the skin closure. The amount of remifentanil required during the surgery was analyzed. After using PCA, data on the use of PCA bolus dose were extracted and analyzed using Excel.
Group A used significantly less remifentanil (1021.4 ± 172.0 μg) than group B (1415.0 ± 330.6 μg; P = .03). The number of PCA bolus dose provided to the patients after surgery was significantly lower in group A (1 h: 1.14 ± 0.9, 2 h: 0.85 ± 0.7) than in group B (1 h: 1.85 ± 0.7, 2 h: 1.45 ± 1.0) until 2 hours after the surgery (1 h, P = .008; 2 h, P = .03), but after 3 hours, there were no significant differences between the 2 groups.
If ultrasound-guided bilateral RSB with 40 mL of 0.35% ropivacaine is performed precisely in patients undergoing open gastrectomy, the requirement for remifentanil during surgery can be reduced. In addition, it significantly reduces the use of PCA bolus dose for acute postoperative pain within 2 hours after surgery.
尽管胃癌手术近期取得了进展,但开放式胃切除术仍是治疗胃癌常用的方法。由于腹部切口较大,手术期间所需的阿片类药物量增加,术后疼痛加剧。众所周知,术后疼痛会对患者的免疫系统产生负面影响。在此,我们对全身麻醉下接受开放式胃切除术的患者进行了超声引导下双侧腹直肌鞘阻滞(RSB),并分析了RSB在开放式胃切除术中的镇痛效果。
共有46例计划接受开放式胃切除术的患者被随机分为2组:A组(n = 21)由在超声引导下接受40 mL 0.375%罗哌卡因RSB的患者组成,B组(n = 20)由接受40 mL生理盐水RSB的患者组成。皮肤缝合后立即为每位患者连接电子注射泵进行患者自控镇痛(PCA)。分析手术期间所需瑞芬太尼的量。使用PCA后,提取PCA推注剂量的使用数据并使用Excel进行分析。
A组使用的瑞芬太尼(1021.4±172.0μg)明显少于B组(1415.0±330.6μg;P = 0.03)。术后给予患者的PCA推注剂量次数,A组(术后1小时:1.14±0.9,术后2小时:0.85±0.7)在术后2小时内明显低于B组(术后1小时:1.85±0.7,术后2小时:1.45±1.0)(术后1小时,P = 0.008;术后2小时,P = 0.03),但术后3小时后,两组之间无显著差异。
如果在接受开放式胃切除术的患者中精确进行超声引导下双侧40 mL 0.35%罗哌卡因RSB,可减少手术期间对瑞芬太尼的需求。此外,它还能显著减少术后2小时内急性术后疼痛的PCA推注剂量使用。